logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table PPP-5. Potency of cannabis products at retail level, 2005 [see all tables in this series...]

Part (i) Minimum, maximum, mean and modal (typical) potency recorded, measured as percentage of THC content

CountryCannabis resin Herbal cannabis
Sample sizeMin.Max.MeanModeSample sizeMin.Max.MeanMode
Belgium 1250.133.916.984.62790.533.815.3818.8
Bulgaria 30.752.213550.1102.42
Czech Republic 10417.287.4101080.
Germany(1)3926 8.6 5870 9
Estonia 110.628.24.385280.0316.63.310.35
France-A 516LT226.58.810100LT2186.16
Luxembourg 580.622.2610.92
Hungary 250.163.53,5; 54180.0161.71,5; 2
Malta 1367.211.510.311.271.5108.59.6
Netherlands(2)55 31.616.9 14 10.46.7
Austria 930.126.47.6 1520.03205.66.3
Poland 660.
Portugal 2251.
Slovakia(3)323.329.313.212.81219 326.17.8
United Kingdom(4)8485.25523312813.4813


 Min = minimum price recorded; Max = maximum price recorded; Mean = mean price recorded. Mode = Most frequent (typical) potency recorded. 

 LT = less than.     

 Data were not available in 2005 for the un-listed EU member states, Turkey and Norway. 

 (1) The value reported as mean is actually the median.   

 (2) Data refer to 2004/2005. 

 (3) The value reported as mean is actually the weighted mean.   

 (4) Data refer to England and Wales only.   


 Reitox national focal points (see Table PPP-5 partii) 

Page last updated: Tuesday, 13 November 2007